Precision BioSciences (DTIL) announced the presentation of preclinical data for its PBGENE-DMD development program for the treatment of ...

EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.

The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

CRISPR, The New Gold Standard? Understanding The Rise Of Genetic Enigineering In India – Part 1. Legal News and Analysis - ...

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

Report Ocean is delighted to unveil an exhaustive analysis of the Philippines Specialty Enzymes Market, presenting a detailed exploration of its various dimensions from 2018 to 2032. Our in-depth ...

A recent review highlights the critical role of DNA exonucleases and endonucleases in immune response and disease management, shedding new light on their potential applications in genomic stability, ...

Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, the Company’s pipeline is comprised of in vivo ...